close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stevanato Group S.p.A. Ordinary Shares (NY:STVN)

13.57 +0.36 (+2.73%)
Official Closing Price Updated: 7:00 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stevanato Group S.p.A. Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
STVN Investors Have Opportunity to Join Stevanato Group S.p.A. Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
Unusual-Volume Stocks: Latest Session's Sharp Declines and Double-Digit Gains ↗
Via Chartmill
News headline image
Lost Money on Stevanato Group S.p.A. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 28.57% Stock Decline
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Lost Money on Stevanato Group S.p.A. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 28.57% Share Price Drop
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Did You Lose Money on Stevanato Group S.p.A. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 28.57% Share Price Decline
From The Law Offices of Howard G. Smith
Via Business Wire
News headline image
Stevanato Group (STVN) Shareholder Investigation Following Stock Decline – Kehoe Law Firm, P.C.
From Kehoe Law Firm
Via GlobeNewswire
News headline image
Stevanato Group Q3 Earnings Call Highlights ↗
Stevanato Group (NYSE:STVN) reported third-quarter 2026 revenue growth of 8% to €326.1 million, supported by continued expansion in its biopharmaceutical and diagnostic solutions business despite... 
Via MarketBeat
Topics Earnings
News headline image
Stevanato (STVN) Q3 2026 Earnings Call Transcript ↗
Biologics demand held firm while GLP-1 volumes shape the 2027 outlook. 
Via The Motley Fool
Topics Earnings
US Stock Gap Movers: Up and Down Names in Today's Session ↗
Via Chartmill
News headline image
Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Participate in Two Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group Q2 Earnings Call Highlights ↗
Stevanato Group (NYSE:STVN) reported second-quarter 2026 revenue growth of 8% as demand for higher-value drug containment and delivery products helped lift profitability, while the company updated its... 
Via MarketBeat
Topics Earnings
News headline image
Stevanato (STVN) Q2 2026 Earnings Call Transcript ↗
Revenue grew 8% as high-value solutions surged 16%, driving adjusted EBITDA up 21%. 
Via The Motley Fool
Topics Earnings
News headline image
Stevanato Group Q2 2026 Earnings Call: Complete Transcript ↗
Stevanato Group (NYSE:STVN) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call... 
Via Benzinga
Topics Earnings
News headline image
Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026
From Stevanato Group S.p.A
Via Business Wire
News headline image
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now ↗
Italian healthcare vials and cartridges maker Stevanato Group and U.S. generic and wholesale pharmaceutical company Cencora are two of the best healthcare buys right now. 
Via The Motley Fool
Topics Economy
News headline image
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato (STVN) Q1 2026 Earnings Transcript ↗
Stevanato (STVN) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Participate in Three Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
From Stevanato Group S.p.A.
Via Business Wire
News headline image
End of an Era: West Pharmaceutical Shares Slide as Longtime CEO Eric Green Announces Retirement
Shares of West Pharmaceutical Services (NYSE: WST) tumbled 5.7% on Tuesday following the announcement that Eric Green, the company’s President, Chief Executive Officer, and Chair of the Board, intends... 
Via MarketMinute
Topics Economy Retirement
News headline image
Stevanato (STVN) Q4 2025 Earnings Call Transcript ↗
Stevanato (STVN) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
From Stevanato Group S.p.A.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.